Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308941 | 12530894 | 1 | I | 20160630 | 0 | 20160705 | 20160705 | DIR | 18.00 | YR | F | N | 150.00000 | LBS | 20160701 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308941 | 12530894 | 1 | PS | KEFLEX | CEPHALEXIN | 1 | Oral | 1 CAPSULE(S) THREE TIMES A DAY TAKEN BY MOUTH | Y | D | 20170627 | 0 | 1 | DF | CAPSULE | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125308941 | 12530894 | 1 | Skin infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125308941 | 12530894 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125308941 | 12530894 | Diarrhoea | |
| 125308941 | 12530894 | Dizziness | |
| 125308941 | 12530894 | Drug hypersensitivity | |
| 125308941 | 12530894 | Dyspnoea | |
| 125308941 | 12530894 | Lethargy | |
| 125308941 | 12530894 | Nausea | |
| 125308941 | 12530894 | Pharyngeal oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125308941 | 12530894 | 1 | 20160629 | 20160630 | 0 |